Latest Insider Transactions at Theravance Biopharma, Inc. (TBPH)
This section provides a real-time view of insider transactions for Theravance Biopharma, Inc. (TBPH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Theravance Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Theravance Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2021
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,404
-0.86%
|
$159,656
$14.05 P/Share
|
|
Aug 20
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
4,307
-1.27%
|
$60,298
$14.05 P/Share
|
|
May 20
2021
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-2.47%
|
$53,873
$17.8 P/Share
|
|
May 20
2021
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
3,410
-1.86%
|
$57,970
$17.8 P/Share
|
|
May 20
2021
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
942
-0.51%
|
$16,014
$17.8 P/Share
|
|
May 20
2021
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,779
-0.86%
|
$64,243
$17.8 P/Share
|
|
May 20
2021
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.17%
|
$73,270
$17.8 P/Share
|
|
May 20
2021
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,194
-2.07%
|
$88,298
$17.8 P/Share
|
|
May 20
2021
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.5%
|
$73,270
$17.8 P/Share
|
|
May 20
2021
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,404
-0.85%
|
$193,868
$17.8 P/Share
|
|
May 20
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.25%
|
$73,270
$17.8 P/Share
|
|
Apr 27
2021
|
Alsup Laurie Smaldone |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+22.02%
|
-
|
|
Apr 27
2021
|
Eran Broshy |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+16.15%
|
-
|
|
Apr 27
2021
|
Robert V Gunderson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+12.61%
|
-
|
|
Apr 27
2021
|
Burton G Malkiel |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+10.75%
|
-
|
|
Apr 27
2021
|
Dean J Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+16.15%
|
-
|
|
Apr 27
2021
|
Susan Molineaux Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+50.0%
|
-
|
|
Apr 27
2021
|
Donal O'Connor |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+18.25%
|
-
|
|
Apr 27
2021
|
George M Whitesides Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+50.0%
|
-
|
|
Apr 27
2021
|
William D Young |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+12.6%
|
-
|
|
Apr 27
2021
|
Deepika Pakianathan |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+35.45%
|
-
|
|
Mar 09
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Open market or private sale
|
Direct |
8,829
-2.5%
|
$176,580
$20.0 P/Share
|
|
Feb 20
2021
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
10,092
-7.3%
|
$181,656
$18.79 P/Share
|
|
Feb 20
2021
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
6,597
-3.5%
|
$118,746
$18.79 P/Share
|
|
Feb 20
2021
|
Brett K Haumann Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,672
-12.82%
|
$642,096
$18.79 P/Share
|
|
Feb 20
2021
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,984
-2.11%
|
$71,712
$18.79 P/Share
|
|
Feb 20
2021
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
26,961
-5.78%
|
$485,298
$18.79 P/Share
|
|
Feb 20
2021
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
31,931
-7.98%
|
$574,758
$18.79 P/Share
|
|
Feb 20
2021
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
8,343
-3.23%
|
$150,174
$18.79 P/Share
|
|
Feb 20
2021
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
31,869
-10.06%
|
$573,642
$18.79 P/Share
|
|
Feb 20
2021
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
110,348
-7.64%
|
$1,986,264
$18.79 P/Share
|
|
Feb 20
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
31,887
-8.3%
|
$573,966
$18.79 P/Share
|
|
Feb 08
2021
|
Ann Brady PRESIDENT, TBIL |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+22.44%
|
-
|
|
Feb 08
2021
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+25.62%
|
-
|
|
Feb 08
2021
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+12.23%
|
-
|
|
Feb 08
2021
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+13.97%
|
-
|
|
Feb 08
2021
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+20.12%
|
-
|
|
Feb 08
2021
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+17.02%
|
-
|
|
Feb 08
2021
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
170,000
+10.53%
|
-
|
|
Feb 08
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+14.46%
|
-
|
|
Feb 08
2021
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+25.62%
|
-
|
|
Dec 14
2020
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
7,500
-5.71%
|
$142,500
$19.47 P/Share
|
|
Dec 03
2020
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Open market or private sale
|
Direct |
4,246
-1.31%
|
$76,428
$18.0 P/Share
|
|
Nov 20
2020
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
2,292
-2.28%
|
$38,964
$17.21 P/Share
|
|
Nov 20
2020
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
3,876
-2.87%
|
$65,892
$17.21 P/Share
|
|
Nov 20
2020
|
Brett K Haumann Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,639
-1.64%
|
$78,863
$17.21 P/Share
|
|
Nov 20
2020
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,214
-1.04%
|
$71,638
$17.21 P/Share
|
|
Nov 20
2020
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.41%
|
$81,719
$17.21 P/Share
|
|
Nov 20
2020
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,798
-1.93%
|
$64,566
$17.21 P/Share
|
|
Nov 20
2020
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.87%
|
$81,719
$17.21 P/Share
|